FDA briefing document on J&J Covid vaccine posted. The data are very strong, the J&J vaccine provides robust efficacy across all demographics and variants; and shows rising protection over time, consistent with belief it's eliciting strong T-Cell response. https://t.co/azdgLIjtXs

— Scott Gottlieb, MD (@ScottGottliebMD) February 24, 2021